Aratana Closes $10 Million Non-Dilutive Financing with Square 1 Bank

March 7, 2013

Square 1 Bank is pleased to provide $10M credit facility to Aratana Therapeutics, a biopharmaceutical company focused on developing innovative medicines for cats and dogs.

To read Aratana's press release, click here.

Back To Press and Events

Privacy + Security | Regulatory Disclosures | FDIC Insurance | Terms of Use

Square 1 Bank and Square 1 Ventures are separate subsidiaries of Square 1 Financial, and Square 1 Asset Management, Inc. is a registered investment advisor and subsidiary of Square 1 Bank. Neither Square 1 Asset Management, Inc. nor Square 1 Ventures is insured by Square 1 Bank, the FDIC, or any other governmental agency, nor are any investments made in or facilitated by these entities insured by the FDIC or any other governmental agency. + Read More

Press Contact

PLEASE NOTE